Activists demand compulsory licence for another life-saving cancer drug

Appellate board's order upholding Natco's CL for sorafenib tosylate may pave way for manufacture of generic version of other patented drugs

Unhappy Bani

March of real estate threatens one of the last patches of native Aravalli forest near Delhi

Brickbats for compulsory licences

US criticises India and BRIC group for strengthening provisions on life-saving medicines

A patent triumph of public interest

New flexibilities make public interest safeguards integral to drug patent rights

Strong medicine for weak drug patents

Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend

Biodiversity—India’s other scandal

CAG slams the national biodiversity authority for allowing questionable patents

A walk through Mangar Bani, a sacred grove near Delhi

Free trade will bind India

Crazy for GI? Think again

The protection of Geographical Indication is not a guarantee that the artisan or producer will benefit; traders can corner the premium

A rather ridiculous gap

Clothing giant Gap’s trademark infringement notice to an NGO selling products made from recycled waste is a curious case

India’s 3 D Message

The Supreme Court judgment in the Novartis case clearly upholds India’s patent laws, not weakens the patent regime

Legislation for a few

Benefits of the Act that encourages conservation of plants reach few farmers

Village refuses to part with forest

People near Chennai plan protest against industrial estate

NCD battle starts now

The UN agreement on non-communicable diseases will get snagged on the issue of intellectual property rights for drugs

Obama takes first dip

The US becomes the first to join a global patents pool to make AIDS drugs cheaper but health workers are sceptical of the initiative

Access, yes. Sharing, no

The access and benefit-sharing protocol on biodiversity may do little to deter multinationals from grabbing the planet’s resources

Yale guide to fighting drug patent barriers

How human rights can be used to challenge oppressive intellectual property laws

Holistic approach

Civil society and all government agencies are responsible for sustainable development

Act before vicious cycle sets in

Without a grazing policy the goat economy can go bust

European Parliament rejects Anti-Counterfeiting Trade Agreement

Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries

Act of omission

Public institutions do not seek permission from the biodiversity authority before genetically manipulating crops

Rajasthan opens farm gates

State ties up with Monsanto, other biotech giants to restructure agriculture

Cipla's audacious move

Why generics maker Cipla has asked government to revoke Novartis patent on respiratory ailment drug

US keeps India out of Priority Foreign Country list of 'worst IP offenders'

US Trade Representative’s Special 301 Report keeps up pressure on India to fall in line with US’ interests

The natco-pfizer test

Natco’s demand for a voluntary licence from Pfizer will establish how well the compulsory licence process works in India